Form 4: Health Catalyst Director Duncan Gallagher Receives 20,807 RSUs

Director Duncan Gallagher of Health Catalyst, Inc. was granted 20,807 Restricted Stock Units (RSUs) on June 13, 2024.

Summary

• On June 13, 2024, Duncan Gallagher, a director of Health Catalyst, Inc. (HCAT), acquired 20,807 shares of common stock in the form of Restricted Stock Units (RSUs).
• The RSUs were granted under the company's 2019 Plan.
• Each RSU represents a contingent right to receive one share of Health Catalyst's common stock.
• The RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.
• Following the transaction, Gallagher directly owns 74,523 shares of Health Catalyst common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (granting of RSUs) which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This is a standard practice for compensating board members and aligning their interests with shareholders in the healthcare technology industry.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in publicly traded companies, particularly in the technology and healthcare sectors.
• The vesting schedule of one year or until the next annual meeting is fairly standard.
• Comparing the size of the grant to grants made to directors at similar-sized healthcare technology companies (e.g., Veeva Systems, Cerner, at the time of acquisition) would provide further context.

Stakeholder Impact

• The RSU grant could have a slightly dilutive effect on existing shareholders.
• The grant incentivizes the director to work towards the long-term success of the company, benefiting all stakeholders.

Key Dates